Quantcast
Last updated on April 21, 2014 at 9:11 EDT

Latest kidney cancer Stories

2014-04-15 23:10:44

A new study published in The Oncologist journal shows that a subset of patients with advanced differentiated thyroid cancer (DTC) and multiple comorbidities in which full-dose sorafenib is considered unsafe can initiate treatment with sorafenib at lower starting doses without adversely affecting efficacy or tolerability compared with full-dose sorafenib. A team of researchers led by Ramona Dadu, MD, at the MD Anderson Cancer Center in Houston, TX, performed a retrospective analysis to...

2014-04-09 08:28:15

SANTA ROSA, Calif., April 9, 2014 /PRNewswire/ -- A new study shows that honokiol, a small molecule polyphenol extract derived from Magnolia officinalis bark, reduces proliferation of renal cell carcinoma. Conducted by researchers at the Cancer Research Laboratory at Indiana University Health, Indiana University School of Medicine, the preclinical study showed that honokiol (HonoPure®, EcoNugenics, Santa Rosa, CA) inhibited two highly aggressive renal cell carcinoma (RCC) cell lines....

2014-03-31 08:28:39

Patients in Ontario and Atlantic Canada face significant challenges accessing oral medications due to their age, cancer type and where they live TORONTO, March 31, 2014 /CNW/ - The CanCertainty Coalition - an unprecedented unification of more than 30 Canadian patient groups, physicians, and health charities today released a powerful video highlighting the significant challenges cancer patients in Ontario and Atlantic Canada face in accessing oral medications. The video's message...

2014-01-30 12:28:54

Study shows impact of educational programs and clinical tools on the treatment of renal cell carcinoma RESTON, Va., Jan. 30, 2014 /PRNewswire-USNewswire/ -- Clinical Care Options (CCO), the leading provider of clinical educational content and technological learning platforms, along with its partners, the Annenberg Center for the Health Sciences and AXDEV Group, announced today that it will present key findings from a national educational needs assessment on renal cell carcinoma in a...

2014-01-04 23:01:12

Scientists in Japan and Austria say the kinase inhibitor temsirolimus stops mesothelioma growth in two different ways. Raleigh, NC (PRWEB) January 04, 2014 A new study published in the journal Oncology Reports and detailed by Surviving Mesothelioma suggests that temsirolimus, a kinase inhibitor used to treat advanced renal cell carcinoma (RCC), may offer a promising new way to treat malignant pleural mesothelioma. The group studied temsirolimus by itself and in combination with the...

2013-12-05 23:23:04

A recent study featured in the latest issue of The Oncologist shows that active smoking greatly diminishes patients’ chances of responding to chemotherapeutic treatment for renal cell carcinoma (RCC). The research team, jointly led by Dr. Michael Carducci from the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD and Dr. Daniel Keizman from the Sackler School of Medicine at Tel Aviv University, conducted a retrospective analysis exploring the association of...

2013-12-04 08:26:16

LONDON, December 4, 2013 /PRNewswire/ -- Never thought you would? Luckily, we've done the hard work for you. And Roman isn't the only one to get the 'sexy' football treatment in James Husbands' second annual calendar range. Following the success of last year's hilarious - and frankly disturbing (still enjoying that image of Roman, anyone?) - Sexy Managers' Calendar, James has expanded this year's range to include...

2013-11-11 08:28:34

Analysis of Phase 2 data evaluating induced memory T cell immunity following treatment with AGS-003 in combination with sunitinib presented at the 2013 Annual Meeting of the Society for Immunotherapy of Cancer (SITC). DURHAM, N.C., Nov. 11, 2013 /PRNewswire/ -- Argos Therapeutics Inc., a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis(TM) technology...

2013-11-07 16:27:49

LONDON, November 7, 2013 /PRNewswire/ -- Never thought you would? Luckily, we've done the hard work for you. And Mike isn't the only sporting great to get the 'sexy' treatment in James Husbands' second annual sporting calendar range. Following the success of last year's hilarious - and frankly disturbing (still enjoying that image of Mike Tyson, anyone?) - Sexy Managers' Calendar, James has expanded this year's range to include...

2013-11-04 23:00:12

Foundation Financial Group has concluded a national philanthropic initiative that supported of one of the company’s employees and his daughter. The initiative, For a Cancer Free Katrina, provided FFG employees with an opportunity to give donations to the Bolter family as Katrina Bolter undergoes chemotherapy treatments for a rare type of childhood cancer. Rochester, New York (PRWEB) November 05, 2013 Foundation Financial Group has concluded a national philanthropic initiative that...